Industry Voices

May 20, 2020

Medacta CEO Confident in Orthopedics’ Fundamentals

Medacta CEO Confident in Orthopedics’ Fundamentals
Mr. Francesco Siccardi opens up about market opportunities, headwinds and strategies for Medacta while dealing with the COVID-19 outbreak.
March 18, 2020

Studies Shed Light on Late-Onset Infection

Studies Shed Light on Late-Onset Infection
While the spine industry has focused on 3D printed cages, enabling technology and minimally invasive surgery, it has forgotten a critical priority: infection prevention, says Aakash Agarwal, Ph.D., Director of Research at Spinal Balance.
February 18, 2020

What is the Future of Orthopedic Innovation? Lessons from HSS

What is the Future of Orthopedic Innovation? Lessons from HSS
In moving to the provider side of orthopedics after spending decades in industry, Doug Leach has learned a valuable lesson: Partner with providers. Not just the surgeon.
February 18, 2020

Mathys CEO Talks People, Technology in Joint Replacement

Mathys CEO Talks People, Technology in Joint Replacement
Benjamin Reinmann, M.D., says that the joint replacement market is moving away from the implant toward services driven by technology and keeping value-based patient care on the radar.

Member-Only Content

SUBSCRIBE Login
January 21, 2020

Utilization Management “New Normal” Means Challenges with Prior Authorizations and Appeals

Utilization Management “New Normal” Means Challenges with Prior Authorizations and Appeals
Spine surgery faces utilization management challenges that are influencing patients' access to care and surgeons' abilities to navigate the current payor environment. Device companies can better serve surgeons and their patients by remaining abreast of changes to the payor climate.

Member-Only Content

SUBSCRIBE Login
January 21, 2020

Spinal Kinetics Founder Shares Keys to Startup Success

Spinal Kinetics Founder Shares Keys to Startup Success
Many of the lessons that Tom Afzal has applied throughout his career he learned while working at American Hospital Supply Corporation—one of the largest medical device companies in the ‘70s-‘80s—his first professional position after college. As part of a management path program, Mr. Afzal was required to work in many functional areas of the company—sales, marketing, finance, production, R&D, quality, etc.

Member-Only Content

SUBSCRIBE Login
December 11, 2019

Startup Spotlight: Carmell Therapeutics Takes Regenerative Medicine to the Next Level with Controlled Degradable Biologic

Startup Spotlight: Carmell Therapeutics Takes Regenerative Medicine to the Next Level with Controlled Degradable Biologic
For years, orthobiologics and other forms of regenerative medicine have sought to mimic and enhance the body's natural ability to heal itself. Carmell Therapeutics has a new approach to that end-goal. The company's proprietary process is designed to bind and cross-link regenerative factors in lyophilized platelet-enriched plasma into solid and semi-solid plasma-based materials to accelerate healing in bone, tendon and wound care.
December 11, 2019

Prior Authorization Chaos is the New Normal for Spine Surgery

Prior Authorization Chaos is the New Normal for Spine Surgery
A 2017 physician survey revealed that 86% of offices' prior authorization activities had increased significantly over the last five years, with the average office spending two full workdays to receive a prior authorization. Kim Norton, Vice President of Reimbursement at Simplify Medical, lends insights on how this trend affects the spine market.

Member-Only Content

SUBSCRIBE Login